Imidacloprid other neonicotinoids

The acute toxicity (i.e., lethal potency) of imidacloprid, other neonicotinoids, and related analogs in mammals is most closely related to potency at the 7 nicotinic receptor subtype, followed in order by potency at 1x4, fSx, 0(3, and aj nicotinic receptors, respectively. However, acute toxicity in mammals involves complex actions (agonist and antagonist) at multiple receptor subtypes and these actions vary greatly with minor changes in chemical structure. 

Recently, resistance to imidacloprid became a serious problem for crop protection. Comparative studies of other neonicotinoids revealed a high crossresistance to acetamiprid and thiamethoxam against imidacloprid-resistant strains [22]. However, bioassays exhibited that 4a has good activity against imidacloprid-resistant strains of brown planthopper (Table IV), showing very low cross-resistance to imidacloprid, as shown in Table V. 

In extending the determinations of IC50 values for displacement potencies of competitors we analyzed in detail also their mode of displacement of [ H]imidacloprid (5). As a most remarkable result, we identified two types of displacement of the labeled compound, which we described as competitive and non-competitive , respectively (Figure 1 Table III). Non-competitive displacement of [ HJimidacloprid was found with thiamethoxam and a number of other neonicotinoids that were all characterized by a common structural feature, namely an iV-Methyl group in the pharmacophore. 

Our studies with aphids clearly suggest that thiamethoxam, like the other examined neonicotoinoids, binds to nicotinic receptors. However, there are clear differences to the other commercial neonicotinoids as documented by a kinetic analysis of competition experiments. While thiamethoxam binds to receptors with nanomolar affinity, micromolar concentrations are required to displace imidacloprid. Further, the interaction between the two compounds is noncompetitive meaning that binding of thiamethoxam reduces the binding capacity of the receptor preparation for imidacloprid but not its affinity. Thiamethoxam shares this unusual mode of inhibition with other neonicotinoids (not commercialized) also featured by an W-Methyl group in die pharmacophore. In the competitive mode, displayed by the other commercial neonicotinoids, the capacity is unchanged, while the affinity is reduced. 

Imidacloprid will be used to illustrate the fate of neonicotinoid insecticides (Figure 8.32). Imidacloprid is reduced (1) and then becomes the triazine derivative (2). It can be hydroxv-lated at the imidazole ring to become themonohydroxylated derivatives (3 and 4). Reduction of parent imidacloprid to the nitroso derivative (5) occurs in some animal species. Imidacloprid is also cleaved to become the nitroiminoimidazololidine (6). Further metabolism involves olefin formation (7), glycine conjugation (8), and others. 

The extremely high insecticidal activity of neonicotinoids of the imidacloprid-type 7 (Chapter 29.2.1) triggered extensive research activities within several other companies Ciba-Geigy (later Novartis, now Syngenta), Takeda, Nippon Soda,... 

The synthesis of this compound was first described by Agro Kanesho [16]. Further preparations have been discussed in Section 29.2.3.4. As with all neonicoti-noids, AKD-1022 (12) interacts with nicotinic acetylcholine receptors however, it is much less potent than imidacloprid (8) and other commercial neonicotinoids. In particular, this has been demonstrated with Myzus and Drosophila membranes [23], as well as on American cockroaches [33]. It has been speculated that AKD-1022 (12), as a basic molecule, is ionized in the fluids of insects and, therefore, reaches the synapse only slowly through the lipophilic cuticles and the ion barriers. During retarded movement, the compound is prone to decompose, e.g., due to partial hydrolysis mediated enzymatically and/or non-enzymatically [33]. Therefore, acyclic nitroguanidines such as 19 may also contribute to the insecticidal activity observed in glasshouse and field studies. 

Biochemical experiments with several neonicotinoids on insect membranes showed that both, thiamethoxam and imidacloprid bind to the nicotinic acetylcholine receptor. Imidacloprid however inhibits the binding of thiamethoxam, while not competing for the same binding site. Thiamethoxam and other equally non-competitive neonicotinoids, which only served as research tools, share as a common structural element the N-methyl group at position 5 of the 1,3,5-oxadiazinane ring. 

Like other insecticides, thiamethoxam is transformed in the insect, crop, soil and other compartments to variable degrees to yield products that may not or may be active in their own right. An example for the latter case m the neonicotinoid class is imidacloprid, which is metabolized via hydroxylated intermediates to an olefin product that is more active than the parent compound by one order of magnitude in aphids screens and in receptor binding 20. 21). 

Neonicotinoids target nicotinic acetylcholine receptors as is mostly known from studies with imidacloprid and conveniently sized lab model insects real target pests have not yet been used for technical reasons. Hence, conclusions, especially those on receptor sensitivity, should be taken with care. On the other hand, radioligand binding studies, which usually do not impose technical hurdles, have been widely performed with neonicotinoids using membranes from target and non-target insects. 

---